News Center

Discover all of the trending news of the Ipsen Group


124 results

Innovation

Ipsen joins Biotechnology Innovation Organization (BIO) To A...

Ipsen is delighted to join the Biotechnology Innovation Organization (BIO), the largest association of…

Group

Ipsen appoints Dr. Yan Moore as Senior Vice President, Head ...

Paris (France), 27 September 2018 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointments of Dr.…

Group

Ipsen relocating German affiliate to Munich

Ipsen Pharma GmbH, the German subsidiary of the global specialty-driven biopharmaceutical group Ipsen, has been…

Event

Boston and Paris – two rich ecosystems of R&D excellenc...

Sunday 3rd June Today I’m giving the keynote speech at the second Boston-Paris Biotechnology Summit – this year…

Oncology
Oncology

IPSEN SPONSORS THE STROKE ACTION PLAN FOR EUROPE (2018-2030)

On May 23rd, the Stroke Alliance for Europe (SAFE) and the European Stroke Organization (ESO)…

People

Ipsen Named One of the Best Workplaces in Ireland

Ipsen was recognised as the 12th Best Medium Workplace in Ireland 2018. The Great Place…

Neuroscience

LivingWithNETs.com awarded as Most valuable patient initiati...

LivingWithNETs.com is a dedicated website for patients living with neuroendocrine tumors that was designed with…

Oncology

Exelixis Submits U.S. Supplemental New Drug Application for ...

Access to the press release on Exelixis' website 

Patient

International Childhood Cancer Day, Ipsen mobilizes its team...

The premise is that all children, no matter what their background, have dreams and aspirations.…

Financial information

Ipsen’s Full Year 2017 Financial Results

DAVID MEEK, CEO AYMERIC LE CHATELIER, EXECUTIVE VICE PRESIDENT, FINANCE WILL BE PRESENTING IPSEN’S FULL…

Oncology

Ipsen and Exelixis to host joint investor briefing on Phase ...

Ipsen and its partner Exelixis will jointly host a live investor briefing at the 2018…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021